Chk2 Monoclonal Antibody
Prices are excluding VAT and shipping costs
Product information
| Price | €240, €410 |
|---|---|
| Size | 50 µl/µg | 100 µl/µg |
| Short name | Serine, threonine-protein kinase Chk2 |
| Host | Mouse |
| Isotype | IgG |
| Target protein | CHEK2 |
| Recommended applications | ELISA, ICC, IF, IHC-p, WB |
| Reactivity | Human |
| Immunogen | Purified recombinant fragment of human Chk2 (aa481-531) expressed in E. Coli. |
| Purification | Affinity purification |
| Formulation | Ascitic fluid containing 0.03% sodium azide;0.5% BSA; 50%glycerol. |
| Storage | -20°C for 1 year |
| Product code | MB-AM10366 |
Additional information
Prev
Next
In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutati
CHEK2, CDS1, CHK2, RAD53, Serine, threonine-protein kinase Chk2, CHK2 checkpoint homolog, Cds1 homolog, Hucds1, hCds1, Checkpoint kinase 2
Human: O96017, Mouse: Q9Z265
Human: 11200